文献速递复苏、休克与脓毒症创伤与烧伤儿科与产科急症

高晶体液量抵消儿童战时创伤伤员止血复苏的获益

High crystalloid volumes negate benefit of hemostatic resuscitation in pediatric wartime trauma casualties.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论在大量输血的儿童战时创伤伤员中,低晶体液联合高新鲜冰冻血浆/浓缩红细胞比值与生存改善相关,而高晶体液量时该获益被抵消,尤其在小年龄儿童中。

该回顾性比较研究查询国防部创伤登记库,纳入2007年1月至2016年1月伊拉克和阿富汗战争中接受至少40 mL/kg总血制品且至少1 U浓缩红细胞的儿童伤员521例(占登记 encounters 的15.1%)。按晶体液量高低(40 mL/kg为界)及新鲜冰冻血浆/浓缩红细胞、血小板/浓缩红细胞比值分组,回归模型调整损伤机制、复合损伤严重度评分和总血制品量。低晶体液组中,新鲜冰冻血浆/浓缩红细胞>1:2与生存改善相关(OR 3.42);高晶体液组中,血小板/浓缩红细胞>1:6总体(OR 0.46)及小年龄儿童新鲜冰冻血浆/浓缩红细胞>1:2(OR 0.28)与更差生存相关,其余关联未达统计学显著。作者认为高比值获益在高晶体液量时被抵消,尤其在小年龄儿童。

要点

  • 儿童战时创伤伤员接受至少40 mL/kg总血制品且至少1 U浓缩红细胞时,低晶体液组中新鲜冰冻血浆/浓缩红细胞>1:2与生存改善相关(OR 3.42)。
  • 高晶体液复苏组中,血小板/浓缩红细胞>1:6总体与更差生存相关(OR 0.46)。
  • 高晶体液组中小年龄儿童(0-7岁)新鲜冰冻血浆/浓缩红细胞>1:2与更差生存相关(OR 0.28)。
  • 作者认为高新鲜冰冻血浆/浓缩红细胞比值的生存获益在高晶体液量时被抵消,尤其在小年龄儿童。
  • 作者建议未来评估血制品比值的止血复苏研究应同时计入晶体液和胶体液用量。

适用人群与场景

  • 2007年1月至2016年1月伊拉克和阿富汗战争中进入国防部创伤登记库的儿童(0-17岁)伤员,接受至少40 mL/kg总血制品且至少1 U浓缩红细胞。
  • 按年龄分为小年龄(0-7岁)和大年龄(8-17岁)。

诊断标准与关键阈值

  • 高 versus 低晶体液复苏以40 mL/kg为阈值。
  • 新鲜冰冻血浆/浓缩红细胞低比值定义为≤1:2,高比值定义为>1:2。
  • 血小板/浓缩红细胞低比值定义为≤1:6,高比值定义为>1:6。

研究设计与关键结果

  • 回顾性比较研究,国防部创伤登记库中儿童 encounters 共3,439例,521例(15.1%)符合纳入标准。
  • 纳入伤员中位年龄10岁(四分位距5-13),男性73.5%,中位损伤严重度评分17(四分位距13-25)。
  • 回归模型调整损伤机制、复合损伤严重度评分和总血制品量(基于mL/kg)。
  • 低晶体液组中,新鲜冰冻血浆/浓缩红细胞>1:2与生存改善相关(OR 3.42)。
  • 高晶体液组中,血小板/浓缩红细胞>1:6总体与更差生存相关(OR 0.46)。
  • 高晶体液组小年龄儿童中,新鲜冰冻血浆/浓缩红细胞>1:2与更差生存相关(OR 0.28)。
  • 其余关联未达统计学显著。

证据类型、等级与局限

  • 证据类型:回顾性、比较性研究,证据等级III级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在大量输血的儿童创伤伤员中,高新鲜冰冻血浆/浓缩红细胞比值联合低晶体液量与生存相关,而高晶体液量时该获益被抵消,尤其在小年龄儿童。
  • 作者建议未来评估血制品比值的止血复苏研究应同时计入晶体液和胶体液用量。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Recent data for adult trauma patients suggest improved survival when using hemostatic resuscitation, which includes limiting crystalloids and using closer to 1:1 ratios for both fresh frozen plasma (FFP) and platelets (PLTs) relative to packed red blood cells (PRBCs). Pediatric studies have shown similar but mixed results and often lack measuring crystalloids. We seek to evaluate in-hospital survival based on crystalloid administration and different blood product ratios in pediatric casualties during the recent conflicts.

METHODS: We queried the Department of Defense Trauma Registry for all pediatric encounters in Iraq and Afghanistan from January 2007 to January 2016 and included those with at least 40 mL/kg of total blood products administered provided that they received at least 1 U of PRBC. We grouped children as younger (0-7 years) and older (8-17 years). We grouped low versus high ratios for FFP/PRBC (≤1:2 vs. >1:2) and PLT/PRBC (≤1:6 vs. >1.6). We used a threshold of 40 mL/kg to for high versus low crystalloid resuscitation.

RESULTS: During this time, there were 3,439 encounters in the registry with 521 (15.1%) that met the inclusion criteria. The median age of casualties that met the inclusion was 10 years (interquartile range, 5-13), most were male (73.5%), with a moderate median injury severity score (17; interquartile range, 13-25). We performed regression modeling with adjustments for mechanism of injury, composite injury severity score, and total blood product volume (mL/kg based), grouping children based on high versus low fluid resuscitation. In the low-volume crystalloid group, we found that higher (>1:2) FFP/PRBC was associated with improved survival (odds ratio [OR], 3.42). However, in the high fluid crystalloid resuscitation group, we found that that higher ratios for PLT/PRBC (>1:6) overall (OR, 0.46) and the FFP/PRBC (>1:2) in younger children (OR, 0.28) was associated with worse survival. The remaining associations were not statistically significant.

CONCLUSION: We found an association with survival in massively transfused pediatric trauma patients who received both a high FFP/PRBC ratio and low crystalloid administration. The benefit of this high ratio is negated, in patients receiving high crystalloid volumes, particularly among smaller children. Future studies on hemostatic resuscitation evaluating blood product ratios should also account for crystalloid and colloid administration.

LEVEL OF EVIDENCE: Retrospective, comparative, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Schauer SG, April MD, Becker TE, et al. High crystalloid volumes negate benefit of hemostatic resuscitation in pediatric wartime trauma casualties. J Trauma Acute Care Surg. 2020. PMID: 31972756. doi:10.1097/TA.0000000000002590

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。